MedTrace Logo

Effect of BMS-986165 on the Blood Levels of Metformin

NCT04671953 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2021-11-11

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of BMS-986165 on the drug levels of metformin in healthy participants.

Conditions

  • Healthy Participants

Interventions

DRUG

BMS-986165

Specified dose on specified days

DRUG

Metformin

Specified dose on specified days

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-18
Primary Completion
2021-03-03
Completion
2021-03-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04671953 on ClinicalTrials.gov